These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2921600)

  • 21. Serum and mucosal immunologic responses in children following the administration of a new inactivated intranasal anti-influenza vaccine.
    Greenbaum E; Furst A; Kiderman A; Stewart B; Levy R; Schlesinger M; Morag A; Zakay-Rones Z
    J Med Virol; 2001 Sep; 65(1):178-84. PubMed ID: 11505461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab.
    Kaine JL; Kivitz AJ; Birbara C; Luo AY
    J Rheumatol; 2007 Feb; 34(2):272-9. PubMed ID: 17304653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased incidence of IgA antibodies to the Epstein-Barr virus-associated viral capsid antigen and early antigens in patients with chronic lymphocytic leukemia.
    Dölken G; Bross KJ; Hecht T; Brugger W; Löhr GW; Hirsch FW
    Int J Cancer; 1986 Jul; 38(1):55-9. PubMed ID: 3013785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.
    Desheva YA; Smolonogina TA; Donina SA; Rudenko LG
    BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of amantadine in the prophylaxis of influenza A (H1N1) virus infection: a controlled field trial among young adults and high-risk patients.
    Pettersson RF; Hellström PE; Penttinen K; Pyhälä R; Tokola O; Vartio T; Visakorpi R
    J Infect Dis; 1980 Sep; 142(3):377-83. PubMed ID: 7003032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity.
    Liew FY; Russell SM; Appleyard G; Brand CM; Beale J
    Eur J Immunol; 1984 Apr; 14(4):350-6. PubMed ID: 6609824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic and mucosal isotype-specific antibody responses in pigs to experimental influenza virus infection.
    Heinen PP; van Nieuwstadt AP; Pol JM; de Boer-Luijtze EA; van Oirschot JT; Bianchi AT
    Viral Immunol; 2000; 13(2):237-47. PubMed ID: 10893003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative evaluation of immunofluorescent (IgM and IgG) and complement-fixing antibodies in influenza A infection.
    Masihi KN; Köhler H; Lange W
    Zentralbl Bakteriol Orig A; 1979 Jun; 244(1):17-24. PubMed ID: 388933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Class-specific antibody responses in school children vaccinated with an A/Brazil/11/78 (H1N1)-like recombinant influenza virus prepared from the A/Leningrad/134/57 paediatric cold-adapted donor strain.
    Slepushkin AN; Patriarca PA; Obrosova-Serova NP; Harmon MW; Kupryashina LN; Cheshik SG; Vartanyan RB; Alexandrova GI; Polezhaev FI; Lonskaya NI
    Vaccine; 1988 Feb; 6(1):25-8. PubMed ID: 3354254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine.
    Richt JA; Lekcharoensuk P; Lager KM; Vincent AL; Loiacono CM; Janke BH; Wu WH; Yoon KJ; Webby RJ; Solórzano A; García-Sastre A
    J Virol; 2006 Nov; 80(22):11009-18. PubMed ID: 16943300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The sequential appearance of antibody and immunoglobins in nasal secretion after immunization of volunteers with live and inactivated influenza B virus vaccines.
    Downie JC
    J Hyg (Lond); 1973 Sep; 71(3):433-45. PubMed ID: 4518342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maternal-infant transfer of influenza-specific immunity in the mouse.
    Reuman PD; Paganini CM; Ayoub EM; Small PA
    J Immunol; 1983 Feb; 130(2):932-6. PubMed ID: 6848601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral Fluids as a Live-Animal Sample Source for Evaluating Cross-Reactivity and Cross-Protection following Intranasal Influenza A Virus Vaccination in Pigs.
    Hughes HR; Vincent AL; Brockmeier SL; Gauger PC; Pena L; Santos J; Braucher DR; Perez DR; Loving CL
    Clin Vaccine Immunol; 2015 Oct; 22(10):1109-20. PubMed ID: 26291090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful treatment of juvenile chronic arthritis with a specific antiviral agent.
    Pritchard MH; Munro J
    Br J Rheumatol; 1989 Dec; 28(6):521-4. PubMed ID: 2590807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune response of pregnant cows to bovine rotavirus immunization.
    Saif LJ; Smith KL; Landmeier BJ; Bohl EH; Theil KW; Todhunter DA
    Am J Vet Res; 1984 Jan; 45(1):49-58. PubMed ID: 6322624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment.
    Hayden FG; Treanor JJ; Fritz RS; Lobo M; Betts RF; Miller M; Kinnersley N; Mills RG; Ward P; Straus SE
    JAMA; 1999 Oct; 282(13):1240-6. PubMed ID: 10517426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of age on cytotoxic T lymphocyte memory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine.
    Powers DC; Belshe RB
    J Infect Dis; 1993 Mar; 167(3):584-92. PubMed ID: 8440930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of immunomodulator adamantylamide dipeptide on antibody response to influenza subunit vaccines and protection against aerosol influenza infection.
    Masihi KN; Lange W; Schwenke S; Gast G; Huchshorn P; Palache A; Masek K
    Vaccine; 1990 Apr; 8(2):159-63. PubMed ID: 2336875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase I, randomized, controlled trial to study the reactogenicity and immunogenicity of a nasal, inactivated trivalent influenza virus vaccine in healthy adults.
    Halperin SA; Smith B; Clarke K; Treanor J; Mabrouk T; Germain M
    Hum Vaccin; 2005; 1(1):37-42. PubMed ID: 17038827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mucosal (SIgA) and serum (IgG) immunologic responses in young adults following intranasal administration of one or two doses of inactivated, trivalent anti-influenza vaccine.
    Greenbaum E; Engelhard D; Levy R; Schlezinger M; Morag A; Zakay-Rones Z
    Vaccine; 2004 Jun; 22(20):2566-77. PubMed ID: 15193382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.